- Report
- November 2023
- 67 Pages
Global
From €3349EUR$3,500USD£2,787GBP
- Report
- April 2024
- 310 Pages
Global
From €5411EUR$5,853USD£4,350GBP
- Report
- October 2024
- 189 Pages
Global
From €3392EUR$3,545USD£2,823GBP
€3769EUR$3,939USD£3,136GBP
- Report
- October 2024
- 194 Pages
Global
From €3392EUR$3,545USD£2,823GBP
€3769EUR$3,939USD£3,136GBP
- Report
- October 2024
- 264 Pages
Global
From €5215EUR$5,450USD£4,339GBP
- Report
- January 2024
- 150 Pages
Global
From €4641EUR$4,850USD£3,861GBP
- Report
- July 2024
- 146 Pages
Global
From €3731EUR$3,899USD£3,104GBP
- Drug Pipelines
- June 2024
- 240 Pages
Global
From €2871EUR$3,000USD£2,389GBP
- Report
- May 2024
- 166 Pages
Global
From €2392EUR$2,500USD£1,990GBP
- Report
- June 2024
Global
From €4736EUR$4,950USD£3,941GBP
- Report
- December 2023
- 51 Pages
Global
From €4736EUR$4,950USD£3,941GBP
- Report
- June 2024
- 200 Pages
Global
From €7607EUR$7,950USD£6,330GBP
- Report
- July 2024
- 316 Pages
Global
From €4736EUR$4,950USD£3,941GBP
- Report
- October 2024
- 196 Pages
Global
From €3392EUR$3,545USD£2,823GBP
€3769EUR$3,939USD£3,136GBP
- Report
- October 2024
- 191 Pages
Global
From €3392EUR$3,545USD£2,823GBP
€3769EUR$3,939USD£3,136GBP
- Report
- October 2024
- 197 Pages
Global
From €3392EUR$3,545USD£2,823GBP
€3769EUR$3,939USD£3,136GBP
- Report
- October 2024
- 185 Pages
Global
From €3392EUR$3,545USD£2,823GBP
€3769EUR$3,939USD£3,136GBP
- Report
- October 2024
- 192 Pages
Global
From €3392EUR$3,545USD£2,823GBP
€3769EUR$3,939USD£3,136GBP
- Report
- October 2024
- 175 Pages
Global
From €4784EUR$5,000USD£3,981GBP
- Report
- October 2024
- 175 Pages
Global
From €4784EUR$5,000USD£3,981GBP
The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat.
The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more